Stryker (SYK) News
What's actually happening: chronological and provenance-stamped. News is context, not a signal.
The percentage on each card is SYK's move today, from the quote feed. It is the same figure on every headline, not the move on that headline's own date.
Stryker shares plunge 11.8% after Q3 earnings and sales miss estimates, prompting a 2026 outlook cut amid weak joint procedures and execution challenges.…
SAN FRANCISCO, Oct. 30, 2026 /PRNewswire/ -- On September 8, 2026, investors in Stryker Corporation (NYSE: SYK) saw the price of their shares fall $26.70 (-8.8%) after the company's CFO revealed that a previously-thought…
Stryker cuts its 2026 outlook amid weaker joint replacement demand and supply disruptions, despite MedSurg strength, margin gains and robotics investments.…
Stryker NYSE: SYK reported third-quarter organic sales growth of 7.7% and adjusted earnings per share of $3.52, while lowering its full-year outlook to reflect a slowdown in hip and knee procedures, lingering peripheral …
Stryker Corp. (NYSE:SYK) on Thursday posted weaker-than-expected third-quarter results.…
Medical device maker Stryker (NYSE:SYK | SYK Price Prediction) shares fell about 10% before the open Friday to $279.98, compared with Thursday's close of $311.75. The quarter missed expectations on both lines.…
Stryker Corporation (SYK) Q3 2026 Earnings Call Transcript…
Although the revenue and EPS for Stryker (SYK) give a sense of how its business performed in the quarter ended September 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the…
Stryker (SYK) came out with quarterly earnings of $3.52 per share, missing the Zacks Consensus Estimate of $3.56 per share. This compares to earnings of $3.19 per share a year ago.…
Stryker (NYSE:SYK) reported third-quarter financial results on Thursday. The transcript from the company's third-quarter earnings call has been provided below.…
Portage, Michigan, Oct. 29, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the third quarter of 2026:…
SYK's Q3 earnings may reflect strong hospital equipment demand and cybersecurity recovery, but supply constraints, vascular disruptions and margin pressures remain.…
Portage, Michigan, Oct. 27, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) will participate in the 2026 Jefferies Global Healthcare Conference on Tuesday, November 17, 2026, at the Waldorf Hilton and ME Hotel in London. Spe…
Stryker Corporation remains a global leader in medical technologies, with strong segment breadth and robust product innovation. SYK delivered solid financial growth in H1 2026, with revenue up 6.1% and EBITDA rising to $…
Get a deeper insight into the potential performance of Stryker (SYK) for the quarter ended September 2026 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of its key metric…
Portage, Michigan, Oct. 26, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK), a global leader in medical technologies, announced it has completed the acquisition of ZuriMED, a privately held company and developer of the Fiber…
CMH Wealth Management LLC raised its stake in shares of Stryker Corporation (NYSE: SYK) by 9.3% in a recent quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fun…
On October 22, 2026, Stryker Corp (SYK) shares rose 3.2%, reaching a current price of $307.08. This movement comes amid a 52-week range of $267.00 to $392.55, i…
Stryker (SYK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.…
Diversify Advisory Services LLC boosted its holdings in Stryker Corporation (NYSE: SYK) by 11.6% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutiona…
Investors interested in stocks from the Medical - Products sector have probably already heard of Phibro Animal Health (PAHC) and Stryker (SYK). But which of these two stocks presents investors with the better value oppor…
SYK's Sonopet 3 secures FDA clearance, promising enhanced surgical precision and efficiency, with a full commercial launch expected later this fall.…
LOS ANGELES, Oct. 15, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, continues its investigation on behalf of Stryker Corporation (“Stryker” or the “Company”) …
NEW YORK, Oct. 15, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Stryker Corp. ("Stryker" or the "Company") (NYSE: SYK). Such investors are advised to contact Danielle Peyton at new…
BENSALEM, Pa., Oct. 15, 2026 (GLOBE NEWSWIRE) -- Law Offices of Howard G.…
LOS ANGELES, Oct. 14, 2026 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz continues its investigation of Stryker Corporation (“Stryker” or the “Company”) (NYSE: SYK) on behalf of investors concerning the Company's …
Stryker has received FDA 510(k) clearance for Sonopet ® 3 , the latest evolution of its ultrasonic bone and soft tissue removal platform. Developed in collaboration with surgeons, Sonopet 3 delivers enhanced power, preci…
Kept in their own lane. A press release is the company talking, not reporting.
Expected by Jan 29. Report dates come from the data provider's upcoming-earnings feed and are its estimate, not a date the company has set.